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ABSTRACT
Background: Gel polymers are considered as new dosimeters for determining 
radiotherapy dose distribution in three dimensions.
Objective: The ability of a new formulation of MAGIC-f polymer gel was as-
sessed by experimental measurement and Monte Carlo (MC) method for studying the 
effect of gold nanoparticles (GNPs) in prostate dose distributions under the internal 
Ir-192 and external 18MV radiotherapy practices.
Method: A Plexiglas phantom was made representing human pelvis. The GNP shav-
ing 15 nm in diameter and 0.1 mM concentration were synthesized using chemical 
reduction method. Then, a new formulation of MAGIC-f gel was synthesized. The fab-
ricated gel was poured in the tubes located at the prostate (with and without the GNPs) 
and bladder locations of the phantom. The phantom was irradiated to an Ir-192 source 
and 18 MV beam of a Varian linac separately based on common radiotherapy proce-
dures used for prostate cancer. After 24 hours, the irradiated gels were read using a 
Siemens 1.5 Tesla MRI scanner. The absolute doses at the reference points and isodose 
curves resulted from the experimental measurement of the gels and MC simulations 
following the internal and external radiotherapy practices were compared. 
Results: The mean absorbed doses measured with the gel in the presence of the 
GNPs in prostate were 15% and 8 % higher than the corresponding values without the 
GNPs under the internal and external radiation therapies, respectively. MC simulations 
also indicated a dose increase of 14 % and 7 % due to presence of the GNPs, for the 
same experimental internal and external radiotherapy practices, respectively. 
Conclusion: There was a good agreement between the dose enhancement factors 
(DEFs) estimated with MC simulations and experiment gel measurements due to the 
GNPs. The results indicated that the polymer gel dosimetry method as developed and 
used in this study, can be recommended as a reliable method for investigating the DEF 
of GNPs in internal and external radiotherapy practices.  
Keywords
Brachytherapy, Ir-192, MAGIC-f Polymer Gel Dosimeters, Monte Carlo Meth-
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Introduction
Over the recent years, the effect of GNPs in common radio-therapy practices has been studied extensively by using ex-perimental measurements and MC simulations. Although the 
idea of increasing the dose by using some elements with high atomic 
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3
J Biomed Phys Eng 2015; 5(1) 
www.jbpe.orgKhosravi H., Hashemi B., Mahdavi S. R., Hejazi P.
numbers has been proposed several decades 
ago, following the invention and compat-
ibility of GNPs with biological systems, sci-
entists have stimulated to investigate further 
applications of such elements in radiothera-
py practices. The results of most of the stud-
ies in this field have confirmed an increase 
of the radiation absorbed doses to various 
tumors in the presence of GNPs. However, 
the results are still controversial regarding 
the involved and prominent interaction pro-
cesses of ionizing radiation with the GNPs 
resulted in tumor DEFs. The most effective 
parameters affecting the higher doses in-
vestigated by using experimental dosimetry 
and MC methods include: the dimension of 
nanoparticles, high molar concentrations, 
and lower energies of the photons or gamma 
rays used in various studies [1-14].
If the energy of the photon is greater than 
1.02 MeV, the pair production reaction will 
occur and result in the electron and posi-
tron production. Up to 5 MeV of energy, the 
Compton scattering is noticeable. However, 
above 5 MeV, the pair production interaction 
with high atomic number elements becomes 
dominant. Apart from the Compton scat-
tering, the cross section of the photon with 
different materials depends highly on their 
effective atomic number for the photoelec-
tric (Z4) and pair production (Z2.4) interac-
tions [15-16]. Therefore, due to the domi-
nance of the pair production interaction with 
GNP atoms, it is expected that a consider-
able amount of energy is transferred to these 
nanoparticles. Consequently, the relevant 
DEF resulted from the presence of GNPs 
should be proportional to the ratio of the 
mass absorption coefficient (μen/ρ) of these 
nanoparticles to the water as a soft tissue 
equivalent material. The DEFs for the beams 
with different spectrums are expressed by 
the following equation [17]:
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where NP, μen/ρ, kNP, and E represent the 
“nanoparticles”, “mass energy absorption 
coefficient”, “weighting percentage of the 
nanoparticles in the mixture”, and “radiation 
beam energy”, respectively.
Various conventional dosimeters such as ion 
chambers, TLDs and diodes can measure only 
the point doses under limited conditions. The 
film dosimetry can also specify two dimen-
sional dose distributions. Various dosimetry 
methods are often used to confirm radiother-
apy precisions. In brachytherapy, especially 
for evaluating the complex dose distributions 
resulted from interstitial practices, it is im-
possible to use such conventional dosimetry 
methods. Because of high dose gradients in 
such practices, a large number of point do-
simeters with very small sizes are needed to 
be placed around the radiation sources. In ad-
dition, the dose values are highly dependent 
on the location and small movements of such 
dosimeters leading to high levels of dosimet-
ric errors. Moreover, some of the conventional 
dosimeters are not tissue-equivalent and their 
presence causes the distortion of radiation ge-
ometries specified later in dose distributions. 
Even by using the film dosimeters, radiation 
dose distributions can be measured only in a 
two-dimensional surface. These restrictions 
have raised particular attention of research-
ers to use various gel polymers for measuring 
complex dose distributions in radiotherapy 
practices [18-19].
The MAGIC-f gel, as an appropriate three-
dimensional and tissue-equivalent dosimeter, 
has been successfully used to determine quan-
titatively the DEFs resulted from the presence 
of GNPs as a compatible radio-sensitizer in 
various target organs. This gel can be used po-
tentially to assess the effects of using GNPs in 
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radiotherapy practices [20]. Recently, a poly-
acrylamide gel (nPAG) has also been used to 
measure the increase of the absorbed dose rate 
in the presence of GNPs in different energy 
ranges [21]. Overall, the gel dosimetry is re-
ported as an appropriate tool for accurate do-
simetric measurement when the nanoparticles 
are used in radiotherapy practices especially at 
kV energies.
In this study, the effect of GNPs on the DEFs 
in prostate and bladder under conventional 
radiotherapy practices, a kV internal brachy-
therapy (Ir-192 sources) and high MV external 
beam (18 MV energy of a Varian linac), has 
been investigated experimentally by using a 
new formulation of the MAGIC-f gel dosim-
eter as well as by MC simulations done by the 
MCNPX code.
Material And Methods
Design and Construction of Pelvic 
Phantom
The constructed Plexiglas pelvic phan-
tom has an elliptical shape with an overall 
dimension of 200×200×300 mm3 in which 
the positions of the human bladder, pros-
tate, rectum and bone tissue are defined. 
The bladder, prostate, and rectum incorpo-
rated in the phantom have a hollow cylin-
drical form wherein the desired gel can be 
poured. It should be noted that two different 
caps were constructed for the prostate. The 
cap designed for the internal radiotherapy 
practices has appropriate holes to accom-
modate and hold the brachytherapy needle 
sources, while the cap designed for exter-
nal radiotherapy has no hole. The phantom 
was designed and constructed according to 
the model made by CIRS Company (Model 
002PRA, Computerized Imaging Reference 
Systems, USA). Figure 1 shows a view of 
the constructed pelvic phantom.
To obtain the gel dosimeter calibration 
curve, small plastic falcon tubes with a 20 
mm outer diameter, 100 mm height, and 17 
ml volume were used.
Gold Nanoparticle Synthesis
GNPs were produced using gold salt and 
chemical reduction method as proposed by 
Kupiec et al. [22]. The GNPs were synthe-
sized with appropriate amounts of its com-
ponents to have a diameter of 15 nm. The 
average size of our GNPs products was 
proved by using the DLS (Dynamic Light 
Scattering, Malvern, UK) and TEM (Trans-
mission Electron Microscopy) tests.
Incorporating GNPs in the Gel
After fabricating 500 ml of MAGIC-f gel, 
based on its original constituents [23], al-
though with a new formulation, it was di-
vided into two separate volumes of 100 and 
400 ml. Then, the 100 ml volume of the gel 
was transferred to another container wherein 
the GNPs solution was added to reach a 0.1 
mM concentration of the GNPs in the final 
gel mixture. The gel mixture was stirred for 
a period of 5 minutes. Thereafter, the gel 
was poured in the calibration tubes as well 
as the prostate (with or without the presence 
of GNPs), bladder, and rectum containers of 
Figure 1: A View of Constructed Pelvic Phan-
tom
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the pelvic phantom and kept in a refrigerator 
at 4°C.
Treatment Planning and 
Irradiation
CT-Scan images are required for radiother-
apy treatment planning. Therefore, the CT 
scan of the pelvic phantom was performed 
using a Siemens (Germany) scanner. The 
required treatment planning was performed 
for both internal and external radiotherapy 
procedures.
For the external radiotherapy, at first, the 
size, direction, and any other information 
related to the pelvic phantom dimensions 
were calibrated against its image. Then, by 
considering the size and location of the pros-
tate in the phantom, four orthogonal radia-
tion fields were defined for treating prostate 
by using Core PLAN software (Seoul C&J, 
South Korea). The treatment planning speci-
fications are provided in figure 2 and table 1.
For internal brachytherapy practice, the 
required dose is selected from the planning 
target volume (PTV) defined by the oncolo-
gist. Flexiplan software (ELECTA, Sweden) 
was used for our brachytherapy treatment 
planning to compute the location of the 
source (Dwell-position) and the amount of 
the time at each stop location (Dwell-time) 
for this procedure. In the treatment planning 
done for this radiotherapy procedure, iso-
dose curves can be seen on all of the images 
and CT slices. Two different views of the 
isodose curves obtained for this procedure 
can be observed in figure 3.
Prior to implementing internal and external 
radiotherapy planning as described above 
and to calibrate our fabricated MAGIC-f gel, 
the tubes containing the gel were irradiated 
to different levels of known doses measured 
with a calibrated dosimeter provided by the 
Varian linac. After calibrating MAGIC-f gel, 
the phantom was irradiated to the high dose 
rate internal brachytherapy and the 18 MV 
external radiotherapy beams provided by the 
Ir-192 sources and Varian linac separately at 
all radiotherapy stages.
Khosravi H., Hashemi B., Mahdavi S. R., Hejazi P.
Table 1: Treatment Planning Specifications 
Used for 18 MV External Radiotherapy of 
Pelvic Phantom by Varian 2100 linac
 
Figure 2: Treatment planning Performed on 
Pelvic Phantom under 18 MV External Radio-
therapy Procedure by Varian 2100 linac
Energy 18 MV
Number of fields 4
Distance of the source to the center of 
the prostate
100 cm
Field size 6 cm×6 cm
Delivered Dose 200 cGy
Monitor Unit/Fraction 204.9
 
Figure 3: Treatment Planning Performed on 
Pelvic Phantom under Internal Brachythera-
py Procedure by Ir-192 Sources
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MRI Reading and Processing
At 24-hour post of the irradiation proce-
dures, the gels were read using a 1.5 Tesla 
Siemens MRI scanner (Germany). It should 
be reminded that prior to the imaging pro-
cess, the phantom and calibration tubes were 
taken to an isothermal room and kept there 
for a period of 4 hours. MRI imaging pro-
cess was performed according to the proto-
col given in table 2.
as used in the internal and external experi-
mental treatment planning procedures.
Results
The results will be presented from both 
our experimental measurements and MC 
calculations for both of internal and external 
radiotherapy procedures performed in this 
study as described in the previous section. 
At experimental stage, the calibration pro-
cess of the gel resulted in a linear relation-
ship between MRI R2 values and the doses 
received by the calibration gel tubes (figure 
4).
Parameter Value
Field of view (mm) 300
Dimensions of the matrix 256×256
Slice thickness (mm) 4
Time of echo (ms) 22
Pulse repetition time (ms) 3000
Pixel dimensions(mm2) 0.9×0.9
Number of Echo 16
Table 2: Protocol Used for Reading MRI Im-
ages of Pelvic Phantom and Calibration Gel 
Tubes.
 
Figure 4: MAGIC-f Gel Calibration Curve De-
termined from Experimental Measurement
The matrices plotted from MRI R2 signals 
for each section were calculated by MAT-
LAB software. The absolute doses and rela-
tive dose distribution curves were extracted 
from R2 signals of the MRI images.
Monte Carlo Simulation
MCNPX code was used for MC calcula-
tion. After validating linac structures and its 
18 MV photon beam parameters and also 
the Ir-192 sources (based on TG-43 protocol 
[24]), the pelvic phantom was simulated ac-
cording to its actual dimensions. In general, 
five materials were simulated in the pelvic 
phantom including: MAGIC-f gel, GNPs, 
Teflon (representing femur bone) air (repre-
senting rectum) and Plexiglas (representing 
soft tissues of the rest of the pelvic phantom).
The simulated phantom was irradiated 
based on the same conditions and protocols 
The isodose curves of the bladder and 
prostate (with and without the presence of 
GNPs) which were measured experimen-
tally and calculated by MC simulations in 
the pelvic phantom in two different slices, 
located at A) X=+ 0.4 cm and B) X=0 cm, 
for the external radiotherapy procedure are 
presented in figure 5.
The isodose curves of the bladder and 
prostate (with and without the presence of 
GNPs) which were measured experimen-
tally and calculated by MC simulations in 
the pelvic phantom in two different slices, 
located at A) X=+0.4 cm and B) X=0 cm, 
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Figure 5: Comparison of Isodose Curves Measured Experimentally with Gel and Calculated by 
MC Calculations at two Different Slices for18 MV (Varian linac) External Radiotherapy Procedure
for the internal radiotherapy procedure are 
presented in figure 6.
The DEFs measured with the gel and calcu-
lated with MC method at two different slices 
of the pelvic phantom for the external radio-
therapy procedure are presented in figure 7. 
At any region of interest, DEFs were derived 
by dividing the relative amount of the doses 
at any pixel of the images measured/calcu-
lated with the presence of the GNPs.
The mean values of the DEFs estimated 
from the experimental measurements and 
simulated calculations for prostate from 18 
MV external radiotherapy procedures at two 
different slices of the pelvic phantom are 
shown in table 3.
The mean values of the DEFs measured 
experimentally with the gel and calculated 
with MC simulations at the two different 
slices of the pelvic phantom from internal 
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Figure 6: Comparison of Isodose Curves Measured Experimentally with Gel and Calculated by 
MC Calculations at two Different Slices for Internal Brachytherapy (Ir-192) Procedure
Slice X=+0.4 cm X=0 cm Total
DEF(Measured) 1.09± 0.02 1.08± 0.02 1.08± 0.01
DEF(Calculated) 1.078 ± 0.002 1.075 ± 0.002 1.075 ± 0.002
Table 3: Mean Values of DEFs Measured Experimentally with Gels and Calculated by MC Simula-
tions due to the Presence of GNPs in Prostate of the Pelvic Phantom from 18 MV (Varian linac) 
External Radiotherapy Procedure at Two Different Slices
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brachytherapy procedure (with Ir-192 sourc-
es) are presented in figure 8. These DEFs, at 
any region of interest, were also estimated 
by dividing the relative amount of the doses 
at any pixel of the images measured/calcu-
lated with the presence of the GNPs.
The mean values of the experimental and 
simulated DEFs for prostate from internal 
brachytherapy procedure at two different 
slices of the pelvic phantom are shown in 
table 4.
Discussion and Conclusion
In the experimental part of this study, some 
dosimetric specifications of the fabricated 
MAGIC-f gel dosimeter including its linear-
ity and dose resolution were assessed. The 
fabricated gel showed a linear dose response 
in a range of 0-900 cGy with a considerable 
increase up to 50 percent indicating a sat-
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Figure 7: Experimental and Simulated DEFs Resulted from GNPs for Prostate in Pelvic Phantom 
from 18 MV (Varian linac) External Radiotherapy Procedure at two Different Slices (A: X=+0.4 
cm, B: X=0 cm)
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Slice X=+0.4 cm X=0 cm Total
DEF(Measured) 1.18± 0.06 1.14± 0.05 1.15± 0.03
DEF(Calculated) 1.143± 0.002 1.141± 0.005 1.141± 0.004
Table 4: Mean Values of DEFs Measured Experimentally with Gels and Calculated by MC Simu-
lations due to the Presence of GNPs in Prostate of the Pelvic Phantom from Internal Brachy-
therapy (Ir-192) Procedure at two Different Slices
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Figure 8: Experimental and Simulated DEFs Resulted from GNPs for Prostate in Pelvic Phantom 
from Internal Brachytherapy (Ir-192) Procedure at two Different Slices (A: X=+0.4 cm, B:X=0 cm)
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isfactory and well polymerization process. 
The dose response of the gel was also as-
sessed with and without the presence of the 
GNPs for both internal and external radio-
therapy modalities used commonly for pros-
tate cancer treatment in a pelvic phantom. 
Our experimental results with gel dosimeter 
indicated a mean DEF of 9% (SD=1%) and 
15% (SD=3%) due to the presence of the 
GNPs in prostate for external and internal 
radiotherapy procedures, respectively.
The MC method was also used to simulate 
our experimental measurements and calcu-
late DEFs in prostate resulted from GNPs 
for the same common internal and exter-
nal radiotherapy modalities as investigated 
with experimental gel dosimetry method. 
MC results showed a mean DEF of 8.3% 
(SD=0.2%) and 14.1% (SD= 0.4%) due to 
the presence of GNPs in prostate for exter-
nal and internal radiotherapy procedures, re-
spectively.
Both experimental measurements and MC 
calculations indicated higher DEFs in the 
target volume (prostate) for internal brachy-
therapy (Ir-192) of prostate in the presence 
of GNPs compared to those of high energy 
(18MV) external radiotherapy. This must 
have been mainly due to higher probabili-
ties of the photoelectric effect in kV inter-
nal brachytherapy relative to MV external 
radiotherapy modality. Since, despite the in-
creased probability of the pair production in-
teraction at MV energies, the amount of the 
dose increase due to this interaction is less 
than that of the more dominant photoelec-
tric interaction at kV energies [15, 16]. Fur-
thermore, the ratios of the mass absorption 
coefficient (μen/ρ) of gold to water at low 
kVs is higher than those of the high MVs 
[17, 25].Therefore, it is expected that DEF 
in prostate in the presence of GNPs would 
be higher in internal low KV energy as used 
in brachytherapy compared to that of exter-
nal MV energies as used in external radio-
therapy modalities.
There was a good agreement between DEFs 
obtained by MC computational method and 
the experimental gel dosimetry measure-
ments for GNPs concentration used in this 
study. The results demonstrate that fabricat-
ed MAGIC-f gel could be used as a suitable 
three-dimensional dosimeter for more exten-
sive studies at various internal and external 
radiotherapy modalities and also with the 
presence of various concentrations of GNPs.
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